UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Old Republic International
ORI
$10.4B
| $15.4M | 0.01% |
595,255
+18,461
| +3% | +$476K |
|
|
BPMC
877
DELISTED
Blueprint Medicines
BPMC
| $15.3M | 0.01% |
239,976
+5,369
| +2% | +$385K |
|
878
Gentex
GNTX
$5.07B
| $15.3M | 0.01% |
524,018
+28,265
| +6% | +$879K |
|
879
Lamb Weston
LW
$7.19B
| $15.3M | 0.01% |
255,065
+16,000
| +7% | +$994K |
|
880
Essential Properties Realty Trust
EPRT
$6.62B
| $15.2M | 0.01% |
600,870
+36,431
| +6% | +$938K |
|
|
ITCI
881
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.1M | 0.01% |
247,234
+174,038
| +238% | +$9.04M |
|
882
Middleby
MIDD
$6.08B
| $15.1M | 0.01% |
91,902
+4,514
| +5% | +$820K |
|
883
Royal Gold
RGLD
$19.5B
| $15.1M | 0.01% |
106,535
+4,500
| +4% | +$526K |
|
|
IGMS
884
DELISTED
IGM Biosciences
IGMS
| $15M | 0.01% |
560,711
+200,032
| +55% | +$3.72M |
|
885
Manhattan Associates
MANH
$11.4B
| $14.9M | 0.01% |
107,722
+6,161
| +6% | +$825K |
|
|
BERY
886
DELISTED
Berry Global Group, Inc.
BERY
| $14.9M | 0.01% |
280,299
+8,731
| +3% | +$511K |
|
|
ZNGA
887
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $14.9M | 0.01% |
1,613,737
+65,301
| +4% | +$574K |
|
|
PLAN
888
DELISTED
Anaplan, Inc.
PLAN
| $14.8M | 0.01% |
228,137
+36,160
| +19% | +$1.76M |
|
889
Jefferies Financial Group
JEF
$13.1B
| $14.7M | 0.01% |
468,798
+9,619
| +2% | +$327K |
|
890
Lithia Motors
LAD
$8.26B
| $14.4M | 0.01% |
48,036
+4,104
| +9% | +$1.28M |
|
|
ROIC
891
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $14.2M | 0.01% |
733,976
-26,439
| -3% | -$494K |
|
892
Idacorp
IDA
$8.2B
| $14.1M | 0.01% |
122,635
+22,651
| +23% | +$2.47M |
|
893
US Foods
USFD
$24B
| $14.1M | 0.01% |
374,434
-455,687
| -55% | -$16.6M |
|
894
Texas Pacific Land
TPL
$23.5B
| $14.1M | 0.01% |
93,654
+2,673
| +3% | +$352K |
|
|
SF
895
Stifel
SF
$12.6B
| $14.1M | 0.01% |
310,719
+3,040
| +1% | +$146K |
|
896
MKS Inc
MKSI
$20.6B
| $14.1M | 0.01% |
93,684
+2,905
| +3% | +$451K |
|
897
Norwegian Cruise Line
NCLH
$8.84B
| $14M | 0.01% |
640,789
+93,177
| +17% | +$1.9M |
|
898
Denali Therapeutics
DNLI
$3.97B
| $14M | 0.01% |
434,827
-5,209
| -1% | -$179K |
|
899
Five Below
FIVE
$13.5B
| $13.9M | 0.01% |
87,955
+10,987
| +14% | +$1.83M |
|
900
Acadia Pharmaceuticals
ACAD
$5.03B
| $13.9M | 0.01% |
572,345
+30,352
| +6% | +$734K |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.